New PET imaging agent may help measure efficacy or failure of hormone therapy for breast cancer

Physicians may soon have a new way to measure the efficacy or failure of hormone therapy for breast cancer patients, according to new research published in the February issue of The Journal of Nuclear Medicine.

More From BioPortfolio on "New PET imaging agent may help measure efficacy or failure of hormone therapy for breast cancer"